Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Feb 19;2014(2):CD001132.
doi: 10.1002/14651858.CD001132.pub2.

5-Fluorouracil for glaucoma surgery

Elspeth Green  1 , Mark Wilkins, Catey Bunce, Richard Wormald
Affiliations
Meta-Analysis

5-Fluorouracil for glaucoma surgery

Elspeth Green et al. Cochrane Database Syst Rev. .

Abstract

Background: Trabeculectomy is performed as a treatment for many types of glaucoma in an attempt to lower the intraocular pressure. The surgery involves creating a channel through the sclera, through which intraocular fluid can leave the eye. If scar tissue blocks the exit of the surgically created channel, intraocular pressure rises and the operation fails. Antimetabolites such as 5-Fluorouracil (5-FU) are used to inhibit wound healing to prevent the conjunctiva scarring down on to the sclera. This is an update of a Cochrane review first published in 2000, and previously updated in 2009.

Objectives: To assess the effects of both intraoperative application and postoperative injections of 5-FU in eyes of people undergoing surgery for glaucoma at one year.

Search methods: We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2013, Issue 6), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to July 2013), EMBASE (January 1980 to July 2013), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 25 July 2013. We also searched the reference lists of relevant articles and the Science Citation Index and contacted investigators and experts for details of additional relevant trials.

Selection criteria: We included randomised trials of intraoperative application and postoperative 5-FU injections compared with placebo or no treatment in trabeculectomy for glaucoma.

Data collection and analysis: Two authors independently assessed trial quality and extracted data. We used standard methodological procedures expected by The Cochrane Collaboration. We contacted trial investigators for missing information. Data were summarised using risk ratio (RR), Peto odds ratio and mean difference, as appropriate.The participants were divided into three separate subgroup populations (high risk of failure, combined surgery and primary trabeculectomy) and the interventions were divided into three subgroups of 5-FU injections (intraoperative, regular dose postoperative and low dose postoperative). The low dose was defined as a total dose less than 19 mg.

Main results: Twelve trials, which randomised 1319 participants, were included in the review. As far as can be determined from the trial reports, the methodological quality of the trials was not high, including a high risk of detection bias in many. Of note, only one study reported low-dose postoperative 5-FU and this paper was at high risk of reporting bias.Not all studies reported population characteristics, of those that did mean age ranged from 61 to 75 years. 83% of participants were white and 40% were male. All studies were a minimum of one year long.A significant reduction in surgical failure in the first year after trabeculectomy was detected in eyes at high risk of failure and those undergoing surgery for the first time receiving regular-dose 5-FU postoperative injections (RR 0.44, 95% confidence interval (CI) 0.29 to 0.68 and 0.21, 0.06 to 0.68, respectively). No surgical failures were detected in studies assessing combined surgery. No difference was detected in the low-dose postoperative 5-FU injection group in patients undergoing primary trabeculectomy (RR 0.93, 95% CI 0.70 to 1.24). Peroperative 5-FU in patients undergoing primary trabeculectomy significantly reduced risk of failure (RR 0.67, 95% CI 0.51 to 0.88). This translates to a number needed to treat for an additional beneficial outcome of 4.1 for the high risk of failure patients, and 5.0 for primary trabeculectomy patients receiving postoperative 5-FU.Intraocular pressure was also reduced in the primary trabeculectomy group receiving intraoperative 5-FU (mean difference (MD) -1.04, 95% CI -1.65 to -0.43) and regular-dose postoperative 5-FU (MD -4.67, 95% CI -6.60 to -2.73). No significant change occurred in the primary trabeculectomy group receiving low-dose postoperative 5-FU (MD -0.50, 95% CI -2.96 to 1.96). Intraocular pressure was particularly reduced in the high risk of failure population receiving regular-dose postoperative 5-FU (MD -16.30, 95% CI -18.63 to -13.97). No difference was detected in the combined surgery population receiving regular-dose postoperative 5-FU (MD -1.02, 95% CI -2.40 to 0.37).Whilst no evidence was found of an increased risk of serious sight-threatening complications, other complications are more common after 5-FU injections. None of the trials reported on the participants' perspective of care.The quality of evidence varied between subgroups and outcomes, most notably the evidence for combined surgery and low-dose postoperative 5-FU was found to be very low using GRADE. The combined surgery postoperative 5-FU subgroup because no surgical failures have been reported and the sample size is small (n = 118), and the low-dose postoperative 5-FU group because of the small sample size (n = 76) and high risk of bias of the only contributing study.

Authors' conclusions: Postoperative injections of 5-FU are now rarely used as part of routine packages of postoperative care but are increasingly used on an ad hoc basis. This presumably reflects an aspect of the treatment that is unacceptable to both patients and doctors. None of the trials reported on the participants' perspective of care, which constitutes a serious omission for an invasive treatment such as this.The small but statistically significant reduction in surgical failures and intraocular pressure at one year in the primary trabeculectomy group and high-risk group must be weighed against the increased risk of complications and patient preference.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Update results combining searches for intraoperative and postoperative use of 5‐Fluorouracil.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
4
4
Forest plot of comparison: 6 Comparison of subgroups: intraoperative versus postoperative 5‐Fluorouracil (5‐FU) in primary trabeculectomy, outcome: 6.2 Intraocular pressure at 12 months.
1.1
1.1. Analysis
Comparison 1 Regular‐dose postoperative 5‐Fluorouracil (5‐FU) versus control, Outcome 1 Failure at 12 months.
1.2
1.2. Analysis
Comparison 1 Regular‐dose postoperative 5‐Fluorouracil (5‐FU) versus control, Outcome 2 Mean intraocular pressure at 12 months.
2.1
2.1. Analysis
Comparison 2 Regular dose intraoperative 5‐Fluorouracil (5‐FU) versus placebo or control, primary trabeculectomy, Outcome 1 Failure at 12 months.
2.2
2.2. Analysis
Comparison 2 Regular dose intraoperative 5‐Fluorouracil (5‐FU) versus placebo or control, primary trabeculectomy, Outcome 2 Mean intraocular pressure (IOP) at 12 months.
3.1
3.1. Analysis
Comparison 3 Comparison of subgroups: intraoperative versus postoperative 5‐Fluorouracil (5‐FU) in primary trabeculectomy, Outcome 1 Failure at 12 months.
3.2
3.2. Analysis
Comparison 3 Comparison of subgroups: intraoperative versus postoperative 5‐Fluorouracil (5‐FU) in primary trabeculectomy, Outcome 2 Intraocular pressure at 12 months.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Chaudhry 2000 {published data only}
    1. Chaudhry IA, Pasha MA, O'Connor DJ, Weitzman MA, Caprioli J. Randomized, controlled study of low‐dose 5‐fluorouracil in primary trabeculectomy. American Journal of Ophthalmology 2000;130(6):700‐3. - PubMed
Donoso 1998 {published data only (unpublished sought but not used)}
    1. Donoso RF, Armas R, Charlίn R, Eggers A, Schweikart A, Varela H, et al. Randomized prospective study of single intraoperatory exposure A 5‐FU in primary trabeculectomy in open angle glaucoma. [Estudio prospectivo randomizado de exposición interoperatoria única a 5‐FU en trabeculectomía primaria en glaucoma de ángulo abierto]. Archivos Chilenos de Oftalmologìa 1998;55(2):17‐25.
FFSSG 1989 {published data only}
    1. Anonymous. Five‐year follow‐up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group. American Journal of Ophthalmology 1996;121(4):349‐66. - PubMed
    1. Anonymous. Fluorouracil Filtering Surgery Study one‐year follow‐up. The Fluorouracil Filtering Surgery Study Group. American Journal of Ophthalmology 1989;108(6):625‐35. - PubMed
    1. Anonymous. Three‐year follow up of the Fluorouracil Filtering Surgery Study. American Journal of Ophthalmology 1993;115(1):82‐92. - PubMed
Goldenfeld 1994 {published data only}
    1. Goldenfeld M, Krupin T, Ruderman JM, Wong PC, Rosenberg LF, Ritch R, et al. 5‐Fluorouracil in initial trabeculectomy. A prospective, randomized, multicenter study. Ophthalmology 1994;101(6):1024‐9. - PubMed
Khaw 2002 {published data only}
    1. Khaw PT. More Flow Study. Clinical and Experimental Ophthalmology 2002;30(Suppl):A45.
Leyland 2001 {published data only}
    1. Leyland M, Bloom P, Zinicola E, McAlister J, Rassam S, Migdal C. Single intraoperative application of 5‐Fluorouracil versus placebo in low‐risk trabeculectomy surgery: a randomized trial. Journal of Glaucoma 2001;10(6):452‐7. - PubMed
O'Grady 1993 {published data only}
    1. O'Grady JM, Juzych MS, Shin DH, Lemon LC, Swendris RP. Trabeculectomy, phacoemulsification, and posterior chamber lens implantation with and without 5‐fluorouracil. American Journal of Ophthalmology 1993;116(5):594‐9. - PubMed
Ophir 1992 {published data only}
    1. Ophir A, Ticho U. A randomized study of trabeculectomy and subconjunctival administration of fluorouracil in primary glaucomas. Archives of Ophthalmology 1992;110(8):1072‐5. - PubMed
    1. Ophir A, Ticho U. Encapsulated filtering bleb and subconjunctival 5‐fluorouracil. Ophthalmic Surgery 1992;23(5):339‐41. - PubMed
Ruderman 1987 {published data only}
    1. Ruderman J, Welch D, Smith M, Shoch D. A randomized study of 5 fluorouracil and filtration surgery. American Journal of Ophthalmology 1987;104(3):218‐24. - PubMed
    1. Ruderman JM, Welch DB, Smith MF, Shoch DE. A prospective, randomized study of 5‐fluorouracil and filtration surgery. Transactions of the American Ophthalmological Society 1987;85:238‐53. - PMC - PubMed
Wong 1994 {published data only}
    1. Wong PC, Ruderman JM, Krupin T, Goldenfeld M, Rosenberg LF, Shields MB, et al. 5‐Fluorouracil after primary combined filtration surgery. American Journal of Ophthalmology 1994;117(2):149‐54. - PubMed
Wong 2009 {published data only}
    1. Seah S L, Khaw P T, Minassian D, Foster P J, Husain R, Gazzard G, et al. The Singapore 5‐FU Study: A prospective randomized masked trial of intra‐operative 5‐fluorouracil vs placebo‐ effect on long‐term pressure control and glaucoma progression. Investigative Ophthalmology and Visual Science 2005;46:ARVO E‐abstract 1219.
Yorston 2001 {published data only}
    1. Yorston D, Khaw PT. A randomised trial of the effect of intraoperative 5‐FU on the outcome of trabeculectomy in east Africa. British Journal of Ophthalmology 2001;85(9):1028‐30. - PMC - PubMed

References to studies excluded from this review

Baez 1993 {published data only (unpublished sought but not used)}
    1. Baez KA, Master MR, Gandam S, Raithel E, Wilson RP. Postoperative injections of 5‐Fluorouracil in trabeculectomy combined with cataract extraction. American Academy of Ophthalmology. 1993; Vol. 110.
Buzarovska 2005 {published data only}
    1. Buzarovska KB, Jordanova VD, Vukosavljevi M, Dzajkovska E. Visual acuity after trabeculectomy. Vojnosanitetski Pregled 2005;62(11):797‐801. - PubMed
Donoso 2000 {published data only}
    1. Donoso R, Rodriguez A. Combined versus sequential phacotrabeculectomy with intraoperative 5‐fluorouracil. Journal of Cataract and Refractive Surgery 2000;26(1):71‐4. - PubMed
Egbert 1993 {published data only}
    1. Egbert PR, Williams AS, Singh K, Dadzie P, Egbert TB. A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population. American Journal of Ophthalmology 1993;116(5):612‐6. - PubMed
Gandolfi 1997 {published data only}
    1. Gandolfi SA, Vecchi M. 5‐fluorouracil in combined trabeculectomy and clear‐cornea phacoemulsification with posterior chamber intraocular lens implantation. A one‐year randomized, controlled clinical trial. Ophthalmology 1997;104(2):181‐6. - PubMed
Hefetz 1994 {published data only}
    1. Hefetz L, Keren T, Naveh N. Early and late postoperative application of 5‐fluorouracil following trabeculectomy in refractory glaucoma. Ophthalmic Surgery 1994;25(10):715‐9. - PubMed
Hennis 1991 {published data only}
    1. Hennis HL, Stewart WC. The use of 5‐fluorouracil in patients following combined trabeculectomy and cataract extraction. Ophthalmic Surgery 1991;22(8):451‐4. - PubMed
Lachkar 1997 {published data only}
    1. Lachkar Y, Leyland M, Bloom P, Migdal C. Trabeculectomy with intraoperative sponge 5‐fluorouracil in Afro‐Caribbeans. British Journal of Ophthalmology 1997;81(7):555‐8. - PMC - PubMed
Lamba 1996 {published data only}
    1. Lamba PA, Pandey PK, Raina UK, Krishna V. Short‐term results of initial trabeculectomy with intraoperative or postoperative 5‐fluorouracil for primary glaucomas. Indian Journal of Ophthalmology 1996;44(3):157‐60. - PubMed
Lanigan 1994 {published data only}
    1. Lanigan L, Sturmer J, Baez KA, Hitchings RA, Khaw PT. Single intraoperative applications of 5‐fluorouracil during filtration surgery: early results. British Journal of Ophthalmology 1994;78(1):33‐7. - PMC - PubMed
Lee 1996 {published data only}
    1. Lee JJ, Park KH, Youn DH. The effect of low‐and high‐dose adjunctive mitomycin C in trabeculectomy. Korean Journal of Ophthalmology 1996;10(1):42‐7. - PubMed
Loftfield 1991 {published data only}
    1. Loftfield K, Ball SF. 5‐FU in primary trabeculectomy. A randomised trial. Investigative Ophthalmology and Visual Science 1991;32(4):745.
Oh 1994 {published data only}
    1. Oh Y, Katz LJ, Spaeth GL, Wilson RP. Risk factors for the development of encapsulated filtering blebs. The role of surgical glove powder and 5‐fluorouracil. Ophthalmology 1994;101(4):629‐34. - PubMed

References to studies awaiting assessment

Chiseli 1997 {published data only}
    1. Chiselita D, Rusu V, Branisteanu D, Apatachioaie I, Poiata I, Tatarus C. Intra‐ and postoperative use of 5‐fluorouracil in the surgical treatment of refractory glaucoma [Utilizarea intra si postoperatorie a 5‐fluorouracilului in chirurgia glaucoamelor refractare]. Oftalmologia 1997;41(2):18‐24. - PubMed
El Sayyad 1993 {published data only}
    1. Sayyad F, Helal M, Sherif Z, El‐Maghraby MA. Trabeculectomy with adjunctive intraoperative 5‐fluorouracil (5‐FU) in primary open‐angle glaucoma (POAG). American Academy of Ophthalmology 1993:131.
El Sayyad 2001 {published data only}
    1. Sayyad FF, El‐Tal M, Salah A, ElKholify H, El‐Husseiny M, Saleh MF. A randomized clinical trial of adjunctive intraoperative 5‐FU in bilateral primary open angle glaucoma (POAG): 5‐year results. American Academy of Ophthalmology 2001:149.

Additional references

Begg 1996
    1. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276(8):637‐9. - PubMed
Blumenkranz 1984
    1. Blumenkranz MS, Claflin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Archives of Ophthalmology 1984;102(4):598‐604. - PubMed
Borenstein 2008
    1. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta‐Analysis. Chichester: John Wiley and Sons, 2008.
Briel 2012
    1. Briel M, Bassler D, Wang AT, Guyatt GH, Montori VM. The dangers of stopping a trial too early. The Journal of Bone and Joint Surgery 2012;94(Suppl 1):56‐60. - PubMed
Broadway 1994
    1. Broadway DC, Grierson I, Hitchings RA. Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important?. British Journal of Ophthalmology 1994;78(6):466‐75. - PMC - PubMed
Burr 2012
    1. Burr J, Azuara‐Blanco A, Avenell A, Tuulonen A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD004399.pub3] - DOI - PMC - PubMed
Chen 1997
    1. Chen P, Yamamoto T, Sawada A, Parrish R, Kitazawa Y. Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese Glaucoma Societies. Journal of Glaucoma 1997;6(3):192‐6. - PubMed
Deeks 2011
    1. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Edmunds 2004
    1. Edmunds B, Bunce CV, Thompson JR, Salmon JF, Wormald RP. Factors associated with success in first‐time trabeculectomy for patients at low risk of failure with chronic open‐angle glaucoma. Ophthalmology 2004;111(1):97‐103. - PubMed
FFSSG 1992
    1. The Fluorouracil Filtering Surgery Study Group. Risk factors for suprachoroidal haemorrhage after filtering surgery. American Journal of Ophthalmology 1992;113(5):501‐7. - PubMed
Glanville 2006
    1. Glanville JM, Lefebvre C, Miles JN, Camosso‐Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130‐6. - PMC - PubMed
Gressel 1984
    1. Gressel MG, Parrish RK 2d, Folberg R. 5‐fluorouracil and glaucoma filtering surgery: I. An animal model. Ophthalmology 1984;91(4):378‐83. - PubMed
Heijl 2002
    1. Heijl A, Leske C, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression. Archives of Ophthalmology 2002;120(10):1268‐79. - PubMed
Heuer 1984
    1. Heuer DK, Parrish RK 2d, Gressel MG, Hodapp E, Palmberg PF, Anderson DR. 5‐fluorouracil and glaucoma filtering surgery. II. A pilot study. Ophthalmology 1984;91(4):384‐94. - PubMed
Higginbotham 1996
    1. Higginbotham EJ, Stevens RK, Musch DC, Karp KO, Lichter PR, Bergstrom TJ, et al. Bleb‐related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996;103(4):650‐6. - PubMed
Higgins 2011
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Kass 2002
    1. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open‐angle glaucoma. Archives of Ophthalmology 2002;120(6):701‐13. - PubMed
Kee 1994
    1. Kee C, Kaufman PL. Profound long‐term hypotony without maculopathy after trabeculectomy with antimetabolite. Acta Ophthalmologica 1994;72(3):388‐90. - PubMed
Khaw 1992
    1. Khaw PT, Sherwood MB, MacKay SL, Rossi MJ, Schultz G. Five‐minute treatments with fluorouracil, floxuridine, and mitomycin have long‐term effects on human Tenon's capsule fibroblasts. Archives of Ophthalmology 1992;110(8):1150‐4. - PubMed
Knapp 1987
    1. Knapp A, Heuer DK, Stern GA, Driebe WT. Serious corneal complications of glaucoma filtering surgery with postoperative 5‐fluorouracil. American Journal of Ophthalmology 1987;103(2):183‐7. - PubMed
Lavin 1990
    1. Lavin MJ, Wormald RP, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Archives of Ophthalmology 1990;108(11):1543‐8. - PubMed
Lee 1987
    1. Lee DA, Hersh P, Kersten D, Melamed S. Complications of subconjunctival 5‐fluorouracil following glaucoma filtering surgery. Ophthalmic Surgery 1987;18(3):187‐90. - PubMed
Maier 2005
    1. Maier PC, Funk J, Schwarzer G, Antes G, Falck‐Ytter YT. Treatment of ocular hypertension and open angle glaucoma: meta‐analysis of randomised controlled trials. BMJ 2005;331(7509):134. - PMC - PubMed
Miglior 2005
    1. Miglior S, Zeyen T, Pfeiffer N, Cunha‐Vaz J, Torri V, Adamsons I, et al. Results of the European Glaucoma Prevention Study. Ophthalmology 2005;112(3):366‐75. - PubMed
Mulrow 1997
    1. Mulrow CD, Oxman AD (eds). Cochrane Handbook for Systematic Reviews of Interventions. Oxford: The Cochrane Collaboration, 1997.
NICE 2009
    1. National Institute for Health and Clinical Excellence. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension. [CG85]. London: National Institute for Health and Clinical Excellence 2009. - PubMed
Parrish 1992
    1. Parrish RK. Who should receive antimetabolites after filtering surgery?. Archives of Ophthalmology 1992;110(8):1069‐71. - PubMed
Peterson 1990
    1. Peterson MR, Skuta GL, Phelan MJ, Stanley SA. Striate melanokeratosis following trabeculectomy with 5‐fluorouracil. Archives of Ophthalmology 1990;108(9):1216‐7. - PubMed
Rossetti 1993
    1. Rossetti L, Marchetti I, Orzalesi N, Scorpiglione N, Torri V, Liberati A. Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice?. Archives of Ophthalmology 1993;111(1):96‐103. - PubMed
Shields 1993
    1. Shields MB. Another reevaluation of combined cataract and glaucoma surgery. American Journal of Ophthalmology 1993;115(6):806‐11. - PubMed
Skuta 1987
    1. Skuta GL, Parrish RK. Wound healing in glaucoma filtering surgery. Surveys of Ophthalmology 1987;32(3):149‐70. - PubMed
Stamper 1992
    1. Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5‐fluorouracil. American Journal of Ophthalmology 1992;114(5):544‐53. - PubMed
Stank 1990
    1. Stank TM, Krupin T, Feitl ME. Subconjunctival 5‐fluorouracil‐induced transient striate melanokeratosis. Archives of Ophthalmology 1990;108(9):1210. - PubMed
Sterne 2011
    1. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Vass 2007
    1. Vass C, Hirn C, Sycha T, Findl O, Bauer P, Schmetterer L. Medical interventions for primary open angle glaucoma and ocular hypertension. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD003167.pub3] - DOI - PMC - PubMed
Wilkins 2005
    1. Wilkins M, Indar A, Wormald R. Intra‐operative Mitomycin C for glaucoma surgery. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD002897.pub2] - DOI - PMC - PubMed
Wolner 1991
    1. Wolner B, Liebmann JM, Sassani JW, Ritch R, Speaker M, Marmor M. Late bleb‐related endophthalmitis after trabeculectomy with adjunctive 5‐fluorouracil. Ophthalmology 1991;98(7):1053‐60. - PubMed

References to other published versions of this review

Abdul Karim 2008
    1. Abdul Karim MN, Bhatt UK, Sivaprasad S. Intraoperative 5‐Fluorouracil for glaucoma surgery. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006926] - DOI
Wormald 1998
    1. Wormald RPL, Wilkins M. Antimetabolites and other modifiers of wound healing in glaucoma surgery. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI: 10.1002/14651858.CD001132] - DOI
Wormald 2000
    1. Wormald R, Wilkins MR, Bunce C. Post‐operative 5‐Fluorouracil for glaucoma surgery. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD001132] - DOI - PubMed
Wormald 2001
    1. Wormald R, Wilkins MR, Bunce C. Post‐operative 5‐Fluorouracil for glaucoma surgery. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD001132] - DOI - PubMed

Publication types